AstraZeneca and Avillion win approval for new asthma rescue treatment in adults

AstraZeneca and Avillion unsurprisingly pulled a win on Wednesday for Airsupra in adults, months after an FDA advisory committee voted overwhelmingly in support of the new asthma rescue treatment.